Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).

Yutaka OgataSotaro SadahiroKazuhiro SakamotoTakashi TsuchiyaTakao TakahashiHiroki OhgeToshihiko SatoKen KondoHideo BabaMichio ItabashiMasataka IkedaMadoka HamadaKiyoshi MaedaHiroyuki MasukoKeiichi TakahashiMitsuo KusanoIchinosuke HyodoJunichi SakamotoMasataka TaguriSatoshi Morita

Published in: International journal of clinical oncology (2024)

Japan Registry of Clinical Trials: jRCTs031180155 (date of registration: 25/02/2019), UMIN Clinical Trials Registry: UMIN000007783 (date of registration: 18/04/2012).

Keyphrases

clinical trial
open label
double blind
study protocol
phase ii
early stage
phase iii
randomized controlled trial
free survival
combination therapy